SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

11 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 1227.94 millions, about 13.10% up against Rs. 1085.73 millions recorded during the year-ago period.The Total revenue for the quarter ended December 2024 of  Rs. 149.66  millions  grew by 170.93% from Rs. 55.24 millions.Operating profit surged to 240.12 millions from the corresponding previous quarter of 203.33 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1227.94 1085.73 13.10 3881.30 3395.20 14.32 4734.18 6457.96 -26.69
Other Income 23.72 7.98 197.24 58.33 22.33 161.22 86.86 15.90 446.29
PBIDT 240.12 203.33 18.09 765.00 624.63 22.47 849.51 1129.52 -24.79
Interest 55.09 66.54 -17.21 218.29 236.69 -7.77 296.80 175.61 69.01
PBDT 185.03 136.79 35.27 546.71 387.94 40.93 109.43 953.91 -88.53
Depreciation 68.50 73.54 -6.85 203.86 203.21 0.32 276.20 172.08 60.51
PBT 116.53 63.25 84.24 342.85 184.73 85.60 -166.77 781.83 -121.33
TAX -33.13 8.01 -513.61 29.50 7.99 269.21 -23.49 146.50 -116.03
Deferred Tax -33.13 -5.55 496.94 29.50 -5.57 -629.62 -37.05 -17.08 116.92
PAT 149.66 55.24 170.93 313.35 176.74 77.29 -143.28 635.33 -122.55
Equity 157.92 137.99 14.44 157.92 137.99 14.44 137.99 137.99 0.00
PBIDTM(%) 19.55 18.73 4.42 19.71 18.40 7.13 17.94 17.49 2.60

Bajaj Healthcare Share Price

333.85 -15.10 (-4.33%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×